Compare SCLX & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | BODI |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.1M | 45.8M |
| IPO Year | 2020 | 2020 |
| Metric | SCLX | BODI |
|---|---|---|
| Price | $5.57 | $6.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 54.6K | ★ 58.4K |
| Earning Date | 04-10-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 96.10 |
| EPS | N/A | ★ 0.47 |
| Revenue | $30,253,000.00 | ★ $251,727,000.00 |
| Revenue This Year | $122.52 | N/A |
| Revenue Next Year | $186.30 | $20.48 |
| P/E Ratio | ★ N/A | $13.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.20 | $4.05 |
| 52 Week High | $34.27 | $16.87 |
| Indicator | SCLX | BODI |
|---|---|---|
| Relative Strength Index (RSI) | 33.36 | N/A |
| Support Level | $5.48 | N/A |
| Resistance Level | $7.77 | N/A |
| Average True Range (ATR) | 0.39 | 0.00 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 11.55 | 0.00 |
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
The Beachbody Co Inc is a fitness and nutrition company providing fitness, nutrition, and stress-reducing programs to its customers. a results-oriented company at the intersection of wellness, technology, and media. The company developed one of the original fitness digital streaming platforms with an extensive library of content containing streaming programs and streaming videos. Company products include Digital Subscriptions, Nutritional Products, and Connected Fitness Products, where the majority of revenue is from Digital Subscriptions. The Company has one operating and reporting segment. Geographically operates in the USA and the rest of the world, with maximum revenue from the United States.